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1. IntroductIon
The world wide annual incidence of head and neck cancers 
is around 5.5 lakhs with 3 lakhs death and a male predisposition1.
They mostly constitute squamous cell carcinomas affecting 
oral cavity, pharynx and larynx, where treatment is in isolation 
or in combinations of surgery, chemotherapy and intensity 
modulated radiotherapy (IMRT). In IMRT, focused radiation 
is given to a tumor/lesion, at 2 Gy/day in a 5 day week schedule 
for 35-50 days amounting to 50-70 Gy. Fractionation is meant 
to ensure balance between cancer control and normal tissue 
damage prevention. However, 40 per cent of the IMRT patients 
still experience different types of oral side effects, either 
‘acute’ or ‘chronic’, because salivary glands inadvertently 
fall in the line of ionising radiation2. Acute changes include 
xerostomia, mucositis, taste disturbances, periodontal pain, 
esophagitis, dysphagia and infections. Chronic complications 
would result in xerostomia, trismus, fibrosis, dental caries, 
osteoradionecrosis and malnutrition3. Among all these, 
xerostomia or hyposalivation is an incapacitating oral effect 
seen in both acute and chronic stages of radiotherapy. It is 
imperative to note that xerostomia is also seen in Sjogren’s 
syndrome, Bell’s palsy, cystic fibrosis, granulomatous/graft-
versus-host/thyroid/liver diseases, uncontrolled diabetes, 
amyloidosis and in human immunodeficiency virus infections 
as a sequel of the respective disease processes. However, 
‘radiation induced xerostomia’ is a separate entity in the 
landscape of radiation biosciences. It causes subjective feelings 
such as dryness in the oral cavity/frequent desire to take drinks/
change of diet or objective changes as assessed by saliva 
volume evaluation-Schirmer’s test or by salivary scintigraphy/
dynamic magnetic resonance imaging. The ill-effects of 
radiation induced xerostomia is graded by the LENT-SOMA 
scale (LENT-Late Effects Normal Tissues, with grades 1-4 
and SOMA-Subjective, Objective, Management, and Analytic 
descriptors of toxicity) given by the European Organisation for 
Research and Treatment of Cancer (EORTC) and the Radiation 
Therapy Oncology Group (RTOG). Overall, radiation induced 
xerostomia markedly affects the quality of life (QoL) of head 
and neck cancer patients, to the extent of even disrupting the 
radiotherapy protocol4.
This review takes stock of the current understanding of 
radiation induced xerostomia from three different perspectives: 
biologic, pharmacologic and technologic. Biologic 
advancements would have to be viewed in 2 view points; one 
aiming at effective future biomimetic means for glandular 
regeneration consequent to radiation by identifying the right 
histologic components to be protected in the current and 
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emerging head and neck cancer radiotherapy protocols. Two, 
it would seek further insight both into the radiation insult on 
cells and its response/repair mechanisms and pathways. This 
improved biologic pedestal would aid in the pharmacological 
synthesis of new ‘radioprotectors’ and ‘mitigators’ either 
‘biological’ or ‘chemical’ with a greater therapeutic efficacy. 
Technological innovations may see refinements in radiotherapy 
procedures and a shift from the use of ‘photons’ towards 
‘protons’ in radiotherapy, which may guarantee better ionising 
beam conformation and normal tissue protection.    
    
2. AnAtomIc, hIstologIc, 
developmentAl And neuronAl 
perspectIves In sAlIvAry glAnds
Paired parotid glands are anteroinferior to ears and 
superficial to mandibular angle and ramus, while paired 
submandibular and sublingual glands are inferior to mandible 
in the mouth floor. Minor salivary glands, which are numerous, 
are widely distributed just below oral mucosa in the lips, anterior 
mouth floor, cheeks, soft/posterior hard palate, tonsillar pillars 
and in the anteroventral/posterodorsal tongue. Rodents don’t 
have minor salivary glands in the lips, hard palate and ventral 
tongue. Salivary glands have 2 types of cells: 80 per cent 
acinar and 20 per cent ductal. Acinar cells are either serous 
or mucous, which produce proteins, water and electrolytes. 
Parotids are predominated with serous acini, sublingual with 
mucous acini and submandibular more of serous but less of 
mucous5. Accordingly, parotid saliva is watery, sublingual 
viscous and submandibular moderately viscous. Around 1.5 l 
of saliva is produced per day; submandibular glands: 70 per 
cent, parotids: 20 per cent and sublingual: 5 per cent. Rest 
is from the numerous minor salivary glands. Saliva mainly 
consists of water, electrolytes, proteins, and carbohydrates. It 
has important functions: phonation, chewing, taste perception, 
swallowing, and re-hydration/lubrication/protection of oral 
mucosa by bactericidal thiocyanates/proteolytic enzymes/
antibodies. Saliva also aids in starch digestion, maintains pH 
by buffering action and prevents tooth enamel dissolution and 
do a cleansing of oral cavity by washing away of accumulated 
food debris6.
Secretory end pieces from acini successively increase 
in diameter to form the duct system: intercalated, striated 
and excretory. Acini consist of pyramidal cells with electron 
dense secretory granules, whereas intercalated ducts are made 
of cuboidal cells with less dense granules. Secretory granules 
are subject to circadian rhythm, which undergoes exocytosis 
during feeding activities with secretion of α-amylase. In 
rodents, intercalated ducts join to form ‘granular convoluted 
tubules’, which produce several bioactive proteins5. Striated 
and excretory ducts are made of columnar cells with large 
mitochondria and basolateral invaginations, which give 
increased surface area for ion exchange. Larger excretory ducts 
are made of stratified/pseudo stratified columnar epithelial cells. 
Acinar cell contribute to the fluid and protein part of saliva 
whereas gland ducts express inorganic content. Myoepithelium 
covers the acini and intercalated ducts but not the striated and 
excretory ducts. The long processes of myoepithelial cells 
circumvent the acini where it is spirally arranged in the long 
axis of the intercalated ducts. Myofilaments in these processes 
contain intermediate filaments made of cytokeratin, which 
rhythmically contract to expel saliva. Progenitor cells are 
found between the intercalated and striated ducts, whereas 
stem cells occur in between excretory and striated ducts7.
Though, both can self renew and differentiate, stem cells are 
more primitive and radio resistent compared to progenitor 
cells. During embryogenesis, salivary glands develop from 
‘epithelial-mesenchymal’ interaction. Thereafter, different cell 
lineages develop from the stem and progenitor cells. Acinar, 
myoepithelial and duct differentiation are postnatal events. 
Intercalated ducts have the ability to differentiate to acinar and 
duct cells, while acinar cells cannot differentiate to other cell 
types4. Other than these histologic constituents, aquaporins 
(AQP) are important water channel proteins that regulate 
salivary flow and secretion. They are of different types; AQP1 
(endothelial cells), AQP3 and AQP5 (basolateral and apical cell 
membrane respectively of acinar cells) and AQP8 (basolateral 
membrane of myoepithelial cells)8. Right  perception of the 
histologic elements and key molecules involved in saliva 
secretion are essential for deducing suitable radiation reversal 
means9.
Neuron-epithelial interaction and autonomous nervous 
system (ANS) (parasympathetic/sympathetic) involvement are 
crucial towards gland development and in saliva secretion10. 
Therefore, it is presumed that re-visiting the different types of 
cell interactions during salivary glandular histogenesis may 
open up novel ‘biomimetic’ approaches for its regeneration. 
Nerves and vessels enter into the salivary glands through the 
main excretory duct. Arterial supply goes upstream against the 
salivary flow, which branches to smaller ducts and then to the 
acini. Venous return follows the salivary down flow, where ion 
exchange occurs. Acetylcholine is the main neurotransmitter 
for the sympathetic/parasympathetic neurons whereas 
noradrenalin is the chief neurotransmitter for sympathetic 
neurons. Vasoactive intestinal peptide (VIP), substance P 
and calcitonin gene regulated peptide (CGRP) also mediate 
parasympathetic signalling while neuropeptide y (NPy) 
regulate sympathetic signalling. Cholinergic and muscarinic 
parasympathetic stimulation articulate the watery component of 
saliva while α and β adrenergic sympathetic stimulation elicits 
the organic matter through secretory granular exocytosis11,12.
Anatomically, preganglionic parasympathetic fibers from 
the inferior salivatory nucleus in medulla of brain stem synapse 
to the otic ganglion in the infra temporal fossa. Postganglionic 
fibers then pass through auriculotemporal nerve of fifth 
cranial cranial nerve for the secretion of serous saliva from 
parotids. For submandibular/sublingual glands, preganglionic 
parasympathetic fibers from the superior salivatory nucleus 
in the pons region of the brainstem pass through nervus 
intermedius to join facial nerve. In the mastoid area, these 
fibers pass through chorda tympani nerve and in the infra 
temporal nerves they join the lingual nerve, to synapse at the 
submandibular ganglion for finally innervating submandibular/ 
sublingual glands. Sympathetic salivary centers for all the 
glands are in the upper thoracic segments of the spinal cord. 
Preganglionic fibers from thoracic ganglion synapse with the 
superior cervical ganglion and postganglionic sympathetic 
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fibers reach salivary glands through the external carotid artery 
plexus. Superior cervical ganglionectomy experiments have 
shown the control of sympathetic fibers in salivary secretion10. 
Parasympathetic and sympathetic neurons are derived from 
the neural crest cells. The neural-epithelial communication 
for salivary gland development is evident from the knockout 
mice experiments, which proved the importance of glial cell 
line derived neurotrophic factor (GDNF) in the development 
of submandibular glands11. Similarly, sympathectomy 
experiments have shown reduction in parotid gland weight and 
in its protein synthesis10. This is because; sympathetic nerves 
innervate the gland at birth along with blood vessels and 
assist in acinar and ductal cell differentiation and maturation. 
Other contributions of gland development come from inputs 
arising out of dietary stimulations, cues from circulating 
hormones from thyroid/adrenal/pancreas/gonads and signals 
from extracellular matrix/cell membrane messengers/micro 
RNAs12. An obvious implication of all these would be the role 
of neurons in salivary gland progenitor cell differentiation 
either directly or indirectly. Future research towards salivary 
gland regeneration will therefore have to take into account 
the above mentioned equilibrium between sympathetic and 
parasympathetic contributions.
 
3. locAl And systemIc rAdIAtIon 
responses
Salivary gland cells are post mitotic and well differentiated. 
They have low proliferation rate compared to other tissues in 
the oral cavity like lips, gums and tongue. However, salivary 
glands are highly radiosensitive and show drastic fall in saliva 
production within 24 h following exposure. This is quite 
contrasting and intriguing, reasons of which are now presumed 
to be a combination of acinar cell dysfunctions and cell death. 
The current information of radiation response of salivary glands 
has come from total body irradiation (TBI) animal experiments 
done using radiation from Cobalt-60 or Cesium-137 on rats: 
5-40 Gy, mouse: 1-15 Gy, rhesus monkey: 2.5-15 Gy and 
mini pigs: 15-20 Gy, though none of them closely simulate 
to humans3. Post radiation, gland size and acinar cell number 
decreases; cytoplasm shows mononuclear inflammatory 
infiltrate, but looses secretory granules and eosinophilic 
staining, nucleus enlarges,  becomes hyperchromatic and 
ducts dilate and accumulate cell debris. Nerves lose vesicles 
but shows increase in neuropeptides. Proximal portions are 
more affected, allowing re-growth from distal side. In vascular 
compartment, endothelium is affected. Stroma undergoes 
adiposis and fibrosis, which hinder transport of nutrients and 
oxygen to cells13.
Radiation affects multiple systems, but death within 
first 30days of exposure is due to ‘gastrointestinal’ and 
‘hematopoietic’ effects and are known as ‘acute radiation 
syndrome’ (ARS). Gastrointestinal manifestations results from 
fluid and electrolyte impairments, bacterial sepsis and depletion 
of intestinal stem cells (ISCs). These are usually seen within 
10-12 days of exposure to 8-20 Gy of radiation. Hematopoietic 
effects appear after exposure to 3-8 Gy with thrombocytopenia/
neutropenia due to exhaustion of hematopoietic progenitor 
cells (HPCs). Skin, kidneys and lungs are then affected. 
Figure 1. systemic and local (salivary gland) events following 
ionising radiation exposure       
Carcinogenesis and teratogenesis are late effects14. Ionising 
radiation induces DNA damage through ‘direct’ and ‘indirect’ 
actions. Directly, it breaks the DNA double strand, while 
indirectly it acts through several free radicals. Both can cause 
cell mutation and subsequently cell death. Radiolysis of water 
within the cells is a major event in radiation injury. It produces 
reactive species like hydroxyl ions (OH), which damages DNA, 
proteins and lipids. DNA damages can be of 2 types: double-
strand breaks (DSBs) and base lesions. Correction of double 
strand breakages is mediated through MRN protein complex 
(Mre11, Rad50 and Nbs1). MRN complex binds to the DNA 
breakage points over which ataxia telangiectasia mutated 
(ATM), kinases also attach. It then undergoes phosphorylation 
targeting several key molecules that elicit any one of these: 
DNA repair/DNA survival with residual damage/arrest of cell 
cycle or senescence/apoptosis or cell death. ATM signaling 
also synchronises cell cycle check points like S and G2M, 
which would give adequate time for cells to repair and not 
to let pass the damages to daughter cells. Further, ATM also 
activates cell survival pathways like NF-kB signalling15.Base 
lesions are rectified by base excision repair pathways that use 
DNA polymerases and ligases. Other mechanisms attributed for 
acinar cell death though with less clarity are (i) de-granulation 
of secretory granules, (ii) impairment in aquaporin water 
channels, (iii) calcium signaling mechanisms, and (iv) loss of 
stem/progenitor cells13. All these would cause early and late 
effects of head and neck cancer radiotherapy. Early changes 
(phase 1: 0-10 days, phase 2: 10-60 days) are marked by rapid 
decrease in the salivary flow and late changes (phase 3: 60-120 
days and phase 4: 120-240 days) by senescence of remaining 
acinar cells or death of salivary gland stem and progenitor 
cells. Novel radiation reversal approaches in salivary glands 
need to take all these molecular events into consideration. 
Figure 1 illustrates the systemic and salivary glandular events 
consequent to radiation.
4. bIologIc And surgIcAl 
AdvAncements In sAlIvAry glAnd 
rAdIAtIon countermeAsures  
Salivary acinar cell death through apoptotic pathways 
have been well studied, but role of necrosis and autophagy 
is yet to be deciphered. Acinar apoptosis involve activation 
of tumor suppressor gene p53; regulated by Akt, a serine/
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threonine specific protein kinase. Activation of Akt is by the 
binding of growth factors to kinase subunits like p85 and p110. 
Akt in turn acts on Mouse Double Minute 2 homolog (MDM2) 
gene leading to apoptosis of acinar cells. Mouse models have 
shown increased apoptosis within 8 h - 24 h of radiotherapy 
that accounts for the glandular shrinkage and reduction/
compositional changes in saliva3. Reversing radiation induced 
apoptosis is therefore now an intensely researched area. Kinase 
inhibitors (Roscovitine) have been found to suppress apoptosis 
and temporarily inhibit cell cycle progression (G2/M cell 
cycle) to allow for DNA repair16.
Ligating the main excretory duct is reported to cause 
proliferation of ductal cells, key to which would be the number 
of surviving stem/progenitor cells17. Ascl3+ progenitor cells 
were identified in developing rat submandibular glands. They 
had the capacity to develop into acinar and ductal cells18. 
Other proteins studied for salivary gland progenitor cells are: 
intermediate filament proteins like Keratins (K5, K14 and K19) 
in the cytoplasm, cell surface proteins like aquaporin3, c-kit, 
CD24, CD 49, CD133 and transcription factors like Oct3/4, 
Nanog and Sox2/10 in the nucleus. A prudent approach would 
be to identify the right progenitor population with multiple 
markers, which would have requisites for regeneration9. Insulin 
growth factor 1, keratinocyte growth factor, fibroblast growth 
factors have promoted survival and proliferation of progenitor 
cells13. Isolation of stem cells from salivary glands prior to 
radiotherapy and re-populating them in the ‘ductal area’ after 
radiotherapy is another approach17. In vitro salivary gland 
culture has also been attempted. The salispheres expressed 
salivary gland stem cell markers: CD24, CD29, CD34, CD44, 
CD49, CD90, and CD117 though maintaining pluripotency of 
acinar cells in culture is still a challenge19. Other upcoming 
methods would involve isolation of mesenchymal stem cells 
from bone marrow/adipose/epithelial tissues or from induced 
pluripotent stem (iPS) cells and inducing in vitro differentiation 
into salivary gland cells. They would be then injected into 
the damaged gland sites20. It would employ biodegradable 
scaffolds as templates in oral mucosa from which salivary 
glands could be tissue engineered. In a similar method, efforts 
to differentiate ductal cells into artificial salivary glands with 
acinar and ductal cells have also been attempted. To stimulate 
stem cell population, activation of Wnt/b catenin pathway has 
also been attempted21,22.
Gene therapy is an emerging option in treating radiation 
induced xerostomia23. Transfer of required genes is done 
through viral/non viral vectors, though viral vectors are 
currently explored. However, they carry risk of insertion 
mutations, undue immune responses and the threat of virus 
itself becoming replication competent. One such approach 
focuses on expressing the water channel protein Aquaporin-1 
through an adenoviral vector. unlike other aquaporins, 
AQP-1 has no specificity to cell sides: apical/lateral, but can 
improve water permeability of cell membrane from all sides. 
Introduction of gene AQP1 has increased the saliva secretion 
in rat and pig salivary glands after radiation8. Heat shock 
proteins 25 and 70 injected via adenoviral vector administered 
prior to radiation have given only incomplete protection9. 
Potential toxicities with gene insertions are another issue. 
On the other hand, transfer of DNA through non viral genes 
is challenging and is still in developing stages. Transfer of 
siRNAs through nanoparticles to block pro-apoptotic genes is 
another method. Needless to mention, success of gene therapy 
is directly related to the amount of intact salivary glandular 
parenchyma24.
Growth factors can be potential radiation reversal agents, 
by their role in cell signaling and DNA repair as with protein 
kinase Akt. Prior treatment with Insulin like growth factor 
(IGF1) was found to reduce Akt dependent apoptosis. Similarly, 
keratinocyte growth factor (KGF) and fibroblast growth factor 
(bFGF) could stimulate epithelial cell proliferation in oral/
esophageal mucosa and inhibit apoptosis25. Here, growth 
factors were given to animals prior to radiation or by gene 
transfer through adenovectors26. Nevertheless, expression of 
the transferred gene outside the purview of targeted cell is a 
potential problem. Role of fibroblast growth factor signaling 
in the progenitor cell differentiation was understood from the 
mutation studies done on fibroblast growth factor 10 (FGF10) 
and its receptor FGFR2b, which causes aplasia of lacrimal and 
salivary glands (ALSG: OMIM 602115) and lacrimo-auriculo-
dento-digital syndrome (LADD: OMIM 149730)7.
Considering the importance of submandibular salivary 
glands in resting salivary secretion, benefits of surgically 
relocating the gland has also been explored. Here, salivary 
gland and ganglion are transplanted to the submental space 
away from the direct field of radiation, though the procedure is 
not free from side effects9.
5. phArmAcologIcAl And 
technologIcAl AdvAncements 
In sAlIvAry glAnd rAdIAtIon 
countermeAsures 
Chemical/biological agents used against tissue damages 
from radiation are (i) radioprotectors: given prior to radiation 
and (ii) mitigators: given after radiation exposure but before 
appear of symptoms. They have applications both in cancer 
radiotherapy and in nuclear warfare/accidental radiation 
exposures. They are expected to satisfy certain criteria: 
selective protection to normal tissues, easy deliverability (self 
administered) and capability to reverse the adverse effects 
with minimal toxicity. Radioprotectors might be of critical use 
in protecting salivary gland functions during head and neck 
cancer radiotherapy. However, when used for radiotherapy 
purposes, these carry the risk of tumor protection also.  
Though several agents have been aggressively pursued 
for long time, few have been able to see clinical realisation. 
Amifostine (WR-2721) is a prototype for radioprotectors. 
It was the first drug developed against radiation effects. Its 
mechanism involves de-phosphorylation of the drug by alkaline 
phosphatase, which would liberate an active metabolite (WR-
1065); a free thiol group that can kill free radicals that attack 
DNA, proteins and lipids. Selective deposition of WR-1065 in 
the oral mucosa and salivary glands has been demonstrated. A 
phase III clinical trial in 1999 proved the radioprotective effects 
of amifostine on salivary glands and was approved by FDA 
as a drug for radiation induced xerostomia. However, later it 
was found to cause allergy, vomiting and hypotension. There 
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were also concerns over its tumor protection, but afterwards 
it was proved wrong since tumor cells showed low levels of 
alkaline phosphate activity. yet, as of now, amifostine is not 
used against radiation induced xerostomia. Nitroxidetempol 
and soy-isoflavones are other free radical scavengers evaluated 
in this line27. 
Reversing ‘radiation induced accelerated senescence’ 
in acinar cells is also an emerging option: inhibition of 
‘mechanistic target of rapamycin (mTOR)’ was found to annul 
radiation induced mucositis in mice. Certain antioxidants 
and few other biologic derivates have also been cited for 
radioprotective action. When administered as a transgene 
in a replication deficient adenovirus, superoxide dismutase, 
an antioxidant showed radiation protection by metabolising 
reactive oxygen species in oral, esophagus and lung tissues. 
Gamma-Tocotrienol, an isomer of vitamin E has also shown 
similar actions. Indole derivatives (3, 3’- Diindolylmethane) 
can activate ATM signalling and initiate responses against DNA 
damage. Flagellin protein derivatives (CBLB502/Entolimod) 
from salmonella bacteria have shown binding to toll-like 
receptor 5 (TLR5) in cells and activate NFkB signalling, 
rendering radioprotection in mice. Chlorobenzylsulfone derived 
kinase inhibitors (ON01210 or Ex-RAD) act by repealing 
ATM/p53 signalling. Intestinal cell mitogens (R-spondin1; 29 
kDa, 263 amino acid protein) have been reported to stimulate 
ISC and undo gastrointestinal radiation features through 
Wnt/β-catenin pathway. Certain antibiotics (tetracycline) 
and anti-hypertensives (captopril) have also been reported 
Approach target/ means current status challenges and future trends
Histologic (i) Progenitor cells Progenitor cell markers 
(i) Ascl3+ cells   
(ii) Cytoplasm filament proteins; keratins (K5, K14, 
K19)   
(iii) Cell surface proteins; AQP3, c-kit, CD 24, CD49, 
CD133 
(iv) Transcription factors; Oct3/4, Nanog, Sox2/10 
(i) Identifying and isolating right 
progenitor cells with necessary markers for 
glandular regeneration 
(ii) Growth factor (FGF) induced 
differentiation of progenitor cells   
(ii) Stem cells  (i) Isolation of stem cells from salivary glands prior to 
radiotherapy and ductal re-population  
(ii) In-vitro salivary gland culturing   
(iii) MSCs and iPS differentiation in suitable scaffolds 
for tissue engineering of artificial salivary glands 
Maintaining pluripotency of salivary stem 
cells is yet to be surmounted  
Biologic (i) Apoptosis (i) Apoptosis blocking through kinase inhibitors 
(ii) Down regulation of pro-apoptotic genes through 
siRNAs in nanoparticles 
(iii) Growth factor (IGF1, KGF, FGF) mediated 
apoptosis inhibition   
Intensely researched  
(ii) Gene therapy Gene transfer (AQPs and HSPs) through adenoviral 
vectors 
Risks of mutations, altered immune 
responses and virus transformation    
(iii) Reversal of 
radiation induced 
accelerated senescence  
Inhibition of mTOR  Potential area of research 
(iv) Water channel 
proteins 
Regulation of aquaporins (AQP1, AQP3, AQP5 and 
AQP8) 
Intensely researched
Biomimetics Neural (sympathetic-
parasympathetic) 
-epithelial interactions  
Improved understanding New salivary gland regeneration protocols 
would have to take cues from neural-
epithelial interaction     
Surgical (i) Ligation of duct Ductal  proliferation Based on pending stem/progenitor cells
(ii) Gland repositioning Submandibular gland to sub mental space Refinements awaited 
Pharmacologic (i) Radioprotectors None available as of now   Emerging theme: combination therapy of 
radioprotectors; chemical and biologic  
(ii) Radiation mitigators Experimental stages- Biologic derivatives, 
antioxidants, certain vitamins 
and antibiotics 
Risk of tumour protection with 
radioprotectors needs addressing 
(iii) Palliative  Saliva substitutes / lubricants - artificial saliva (i) Not free of side effects
Saliva stimulants - cholinergic parasympathomimetic 
agents   
(ii) Limited efficacy in improving QoL 
Alternate 
therapies 
(i) Hyperbaric oxygen Evolving Warrant evidences 
(ii) Acupuncture Evolving Warrant evidences
Technologic Proton therapy Evolving To save crucial glandular components 
table 1.  strategies in radiation induced xerostomia management 
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radioprotective, though with less ambiguity in its mechanism15.
Considering the complex nature of radiation damages in terms 
of the multiple systems it affects and the numerous response 
mechanisms it initiates, future applications may warrant use of 
novel formulations of chemical and biologic radioprotectors in 
combinations for effective radiation reversal in salivary glands. 
A change from single to multiple radioprotector regimes may 
be a promising and discreet approach for successful radiation 
protection in salivary glands.     
Agents used for symptomatic/palliative treatment 
of xerostomia are saliva substitutes/lubricants or saliva 
stimulants. Former includes certain mouthwashes and gels 
containing artificial saliva. Latter are mostly cholinergic 
parasympathomimetic agents, which increase salivary secretion 
by stimulation of acinar muscarinic receptors. Pilocarpine 
is a prototype. Its most accepted dose is 5 mg three times 
daily. However, this also causes side effects like headache, 
increased sweating, lacrimation, urination, vasodilatation, 
nausea, dizziness and dyspepsia. Further, it needs to be 
administered with caution in patients with cardiovascular and 
pulmonary diseases. Similar other formulations are cholinergic 
agonists with greater affinity for muscarinic M3 receptors like 
cevimeline and bethanechol which show little cardiac and 
pulmonary effects. Palliative care using these medications has 
the objective of improving QoL of patients but overall efficacy 
of all these are limited28 .
Alternative modes of therapies reported for radiation 
induced xerostomia include hyperbaric oxygen (HBO), 
acupuncture, and electro stimulation. But long term results 
from these still warrant evidences29. New improvements in 
radiotherapy would aim for better conformed radiation beam 
to the best fit of the lesion with reduced volume of normal 
tissue exposure. Improved sparing of salivary glands has been 
attempted with ‘protons’ instead of ‘photons’. Protons permit 
better dose distribution and reduced spot intensity, compared 
to photon radiotherapy30. This has been proved to save the 
excretory ductal area, which houses the stem cell compartment 
and therefore probably could be a better case for glandular 
regeneration after radiotherapy. Table 1 summarises the 
strategies in radiation induced xerostomia.
  
6. conclusIons 
Radiation  induced  xerostomia is a debilitating oral 
condition seen in head and neck cancer patients undergoing 
radiotherapy. The review has sought to bring out the crucial 
histologic elements which could be given preferential 
sheltering during radiotherapy and cell-cell interactions 
that can be simulated for salivary gland regeneration post 
radiotherapy. Further, in the backdrop of systemic responses, 
the effect of radiation on the microscopic and macroscopic 
aspects of salivary glands was assessed. DNA damage and 
ensuing consequences: acinar cell cycle-changes, cell-
senescence, cell-death; through apoptosis, de-granulation, 
aquaporins and signalling and probable resolution of it through 
appropriate interventions in the anti-apoptotic pathways, re-
activation of stem/progenitor cells, tissue engineering and 
gene therapy with particular impetus to growth factors were 
also evaluated. Mechanism of action of currently available 
radioprotectors based on their ability to act on key molecules 
and pathways were also examined. Accordingly; need for 
a paradigm shift from the traditional use of single drugs to 
multiple ones, chemical and biologic radioprotectors, for 
effective radiation countermeasures have been suggested. It 
also took an account of the palliative care, alternate therapies 
and upcoming innovations in radiotherapy which can address 
radiation induced xerostomiafor improving the quality of life 
of head and neck cancer patients.  
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